Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes

Clinical and Experimental Allergy

Volumn 37, Issue 7, 2007, Pages 1074-1082

  Kanda, N ^a   Watanabe, S ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

CCL27; Extracellular signal regulated kinase; Keratinocyte; Leukotriene B 4; Nuclear factor B; Phosphoinositide 3 kinase; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; I KAPPA B; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE B4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CELL ASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IRRITANT DERMATITIS; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; CHEMOKINES, CC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; I-KAPPA B PROTEINS; KERATINOCYTES; LEUKOTRIENE B4; MAP KINASE KINASE KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, LEUKOTRIENE B4; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 34250742584     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02743.x     Document Type: Article

References (35)

1. Morales J, Homey B, Vicari AP et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci USA 1999 96 : 14470 5.
2. Kanda N, Mitsui H, Watanabe S. Prostaglandin E2 suppresses CCL27 production through EP2 and EP3 receptors in human keratinocytes. J Allergy Clin Immunol 2004 114 : 1403 9.
3. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 2003 112 : 1195 202.
4. Homey B, Alenius H, Muller A et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002 8 : 157 65.
5. Kanda N, Koike S, Watanabe S. Interleukin-17 suppresses TNF-α-induced CCL27 production via induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 2005 116 : 1144 50.
6. Ruzicka T, Simmet T, Peskar BA, Ring J. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 1986 86 : 105 8.
7. Barr RM, Brain S, Camp RD et al. Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol 1984 111 : 23 8.
8. Fogh K, Herlin T, Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations. J Allergy Clin Immunol 1989 83 (2 Pt 1) : 450 5.
9. Medoff BD, Tager AM, Jackobek R, Means TK, Wang L, Luster AD. Antibody-antigen interaction in the airway drives early granulocyte recruitment through BLT1. Am J Physiol Lung Cell Mol Physiol 2006 290 : L170 8.
10. Brach MA, de Vos S, Arnold C, Gruss HJ, Mertelsmann R, Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-κB and NF-IL6. Eur J Immunol 1992 22 : 2705 11.
11. Huang L, Zhao A, Wong F et al. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler Thromb Vasc Biol 2004 24 : 1783 8.
12. Aoki Y, Qiu D, Zhao GH, Kao PN. Leukotriene B4 mediates histamine induction of NF-κB and IL-8 in human bronchial epithelial cells. Am J Physiol 1998 274 (6 Pt 1) : L1030 9.
13. Palmblad J, Lerner R, Larsson SH. Signal transduction mechanisms for leukotriene B4-induced hyperadhesiveness of endothelial cells for neutrophils. J Immunol 1994 152 : 262 9.
14. Gaudreau R, le Gouill C, Metaoui S, Lemire S, Stankova J, Rola-Pleszczynski M. Signalling through the leukotriene B4 receptor involves both αi and α16, but not αq or α11 G-protein subunits. Biochem J 1998 335 : 15 8.
15. Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T. A second leukotriene B4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med 2000 192 : 421 32.
16. Qiu H, Johansson AS, Sjöstrom M et al. Differential induction of BLT receptor expression on human endothelial cells by lipopolysaccharide, cytokines, and leukotriene B4. Proc Natl Acad Sci USA 2006 103 : 6913 8.
17. Iizuka Y, Yokomizo T, Terawaki K, Komine M, Tamaki K, Shimizu T. Characterization of a mouse second leukotriene B4 receptor, mBLT2. BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J Biol Chem 2005 280 : 24816 23.
18. Tong WG, Ding XZ, Hennig R et al. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Clin Cancer Res 2002 8 : 3232 42.
19. Yokomizo T, Kato K, Hagiya H, Izumi T, Shimizu T. Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J Biol Chem 2001 276 : 12454 9.
20. Ito N, Yokomizo T, Sasaki T et al. Requirement of phosphatidylinositol 3-kinase activation and calcium influx for leukotriene B4-induced enzyme release. J Biol Chem 2002 277 : 44898 904.
21. Woo CH, You HJ, Cho SH et al. Leukotriene B4 stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J Biol Chem 2002 277 : 8572 8.
22. Schouten GJ, Vertegaal AC, Whiteside ST et al. IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J 1997 16 : 3133 44.
23. Hu J, Nakano H, Sakurai H, Colburn NH. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-κB activation and transformation in resistant JB6 cells. Carcinogenesis 2004 25 : 1991 2003.
24. Kurosu H, Maehama T, Okada T et al. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110β is synergistically activated by the βγ subunits of G proteins and phosphotyrosyl peptide. J Biol Chem 1997 272 : 24252 6.
25. Stoyanov B, Volinia S, Hanck T et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 1995 269 : 690 3.
26. Sun H, King AJ, Diaz HB, Marshall MS. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 2000 10 : 281 4.
27. Huang R, Lian JP, Robinson D, Badwey JA. Neutrophils stimulated with a variety of chemoattractants exhibit rapid activation of p21-activated kinases (Paks): separate signals are required for activation and inactivation of paks. Mol Cell Biol 1998 18 : 7130 8.
28. Kranenburg O, Verlaan I, Hordijk PL, Moolenaar WH. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO J 1997 16 : 3097 105.
29. Carter AB, Knudtson KL, Monick MM, Hunninghake GW. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression. The role of TATA-binding protein (TBP). J Biol Chem 1999 274 : 30858 63.
30. Ozes ON, Mayo LD, Gustin JA et al. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999 401 : 82 5.
31. Kim KW, Kim SH, Lee EY et al. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclearfactor-κB pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells. J Biol Chem 2001 276 : 13186 91.
32. Vestergaard C, Johansen C, Christensen U, Just H, Hohwy T, Deleuran M. TARC augments TNF-alpha-induced CTACK production in keratinocytes. Exp Dermatol 2004 13 : 551 7.
33. Cronshaw DG, Owen C, Brown Z, Ward SG. Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis. J Immunol 2004 172 : 7761 70.
34. Reilly DM, Parslew R, Sharpe GR, Powell S, Green MR. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol 2000 80 : 171 4.
35. Voorhees JJ. Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 1983 119 : 541 7.